Editorial Board
Vladimir V. Poroikov, Institute of Biomedical Chemistry, Moscow, Russian Federation
Alla B. Salmina, Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky, Russian Federation
Ancha Baranova, Metabolic Diseases
School of Systems Biology
College of Science
George Mason University
Fairfax VA
USA, United States
Gennadii M. Verkhivker, Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California San Diego CA, United States
Dr. Alexander V. Veselovsky, Institute of Biomedical Chemistry, Russian Federation
Alexey A. Philchenkov, RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kiev, Ukraine
Alexander E. Kel, geneXplain GmbH
Wolfenbüttel, Germany
Elena N. Kalinichenko, Institute of Bioorganic Chemistry, Minsk, Belarus
Dmitry D. Zhdanov, Institute of Biomedical Chemistry, Moscow, Russian Federation
Vlada Urlacher, Institute of Biochemistry, Heinrich-Heine University Düsseldorf, Düsseldorf, German
Sergey A. Moshkovskiy, Institute of Biomedical Chemistry, Moscow, Russian Federation
Victor G. Zgoda, Institute of Biomedical Chemistry, Moscow, Russian Federation
Konstantin N. Yarigin, Institute of Biomedical Chemistry, Moscow, Russian Federation
Victoria V. Shumyantseva, Institute of Biomedical Chemistry, Moscow, Russian Federation
Alexey S. Ivanov, Institute of Biomedical Chemistry, Moscow, Russian Federation
Vladimir A. Khripach, Institute of Bioorganic Chemistry, Minsk, Belarus
Andrey V. Lisitsa, Institute of Biomedical Chemistry, Moscow, Russian Federation